GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (STU:A1V0) » Definitions » Other Stockholders Equity

Aptorum Group (STU:A1V0) Other Stockholders Equity : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Aptorum Group Other Stockholders Equity?

Aptorum Group's Other Stockholders Equity for the quarter that ended in Dec. 2023 was €0.00 Mil.

Aptorum Group's quarterly Other Stockholders Equity increased from Dec. 2022 (€-0.00 Mil) to Jun. 2023 (€-0.00 Mil) and increased from Jun. 2023 (€-0.00 Mil) to Dec. 2023 (€0.00 Mil).

Aptorum Group's annual Other Stockholders Equity declined from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€-0.00 Mil) but then increased from Dec. 2022 (€-0.00 Mil) to Dec. 2023 (€0.00 Mil).


Aptorum Group Other Stockholders Equity Historical Data

The historical data trend for Aptorum Group's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Other Stockholders Equity Chart

Aptorum Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial - - - - -

Aptorum Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aptorum Group Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Aptorum Group Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptorum Group (STU:A1V0) Business Description

Traded in Other Exchanges
Address
17 Hanover Square, London, GBR, W1S 1BN
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group (STU:A1V0) Headlines

No Headlines